Free Trial
→ Iran's New Leader Just Said Something That Should Terrify Every American (From American Alternative) (Ad)tc pixel Free XNCR Stock Alerts

Xencor (XNCR) News Today

Xencor logo
$11.88 -0.50 (-4.04%)
Closing price 04:00 PM Eastern
Extended Trading
$11.88 -0.01 (-0.04%)
As of 04:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

XNCR Latest News

Xencor, Inc. Common Stock (XNCR)
May 13 at 5:32 PM  |  nasdaq.comhttps://www.nasdaq.com/market-activity/stocks/xncr/analyst-research
Xencor, Inc. (XNCR) Presents at Bank of America Global Healthcare Conference 2026 Transcript
May 13 at 4:02 AM  |  seekingalpha.comhttps://seekingalpha.com/article/4903629-xencor-inc-xncr-presents-at-bank-of-america-global-healthcare-conference-2026-transcript
JPMorgan Chase & Co. Issues Positive Forecast for Xencor (NASDAQ:XNCR) Stock Price
May 12 at 4:17 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30773740
Xencor (NASDAQ:XNCR) Price Target Raised to $14.00 at JPMorgan Chase & Co.
May 11 at 3:32 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/xencor-nasdaqxncr-price-target-raised-to-1400-at-jpmorgan-chase-co-2026-05-11/
Xencor (NASDAQ:XNCR) Cut to Strong Sell at Zacks Research
May 9, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30768203
Xencor (NASDAQ:XNCR) Rating Lowered to Strong Sell at Wall Street Zen
May 9, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/xencor-nasdaqxncr-rating-lowered-to-strong-sell-at-wall-street-zen-2026-05-09/
These Analysts Think Xencor, Inc.'s (NASDAQ:XNCR) Sales Are Under Threat
May 8, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/analysts-think-xencor-inc-nasdaq-111142363.html
Xencor (NASDAQ:XNCR) Downgraded by Zacks Research to "Strong Sell"
May 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/xencor-nasdaqxncr-downgraded-by-zacks-research-to-strong-sell-2026-05-08/
Xencor (NASDAQ:XNCR) Releases Earnings Results, Misses Estimates By $1.06 EPS
May 6, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/xencor-nasdaqxncr-releases-earnings-results-misses-estimates-by-106-eps-2026-05-06/
Xencor Reports First Quarter 2026 Financial Results
May 6, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260506934755/en/xencor-reports-first-quarter-2026-financial-results/
Xencor Highlights XmAb942 Phase 1 Data, Previews TL1A/IL-23 Bispecific XmAb412 at DDW 2026
May 6, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/xencor-highlights-xmab942-phase-1-data-previews-tl1ail-23-bispecific-xmab412-at-ddw-2026-2026-05-06/
Xencor, Inc. (XNCR) Discusses Phase I Results for XmAb942 and Preclinical Data for XmAb412 Transcript
May 5, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4898753-xencor-inc-xncr-discusses-phase-i-results-for-xmab942-and-preclinical-data-for-xmab412
Xencor, Inc. (XNCR) Discusses Phase I Results for XmAb942 and Preclinical Data for XmAb412 - Slideshow
May 5, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4898755-xencor-inc-xncr-discusses-phase-i-results-for-xmab942-and-preclinical-data-for-xmab412
Xencor (XNCR) to Release Quarterly Earnings on Wednesday
May 5, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30759390
Xencor to Host Webcast to Discuss XmAb942 and XmAb412 Data Presentations at DDW
May 4, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260504721570/en/xencor-to-host-webcast-to-discuss-xmab942-and-xmab412-data-presentations-at-ddw/
Xencor (XNCR) Projected to Post Earnings on Wednesday
April 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/xencor-xncr-projected-to-post-earnings-on-wednesday-2026-04-29/
Xencor, Inc. (NASDAQ:XNCR) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
April 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/xencor-inc-nasdaqxncr-receives-consensus-recommendation-of-moderate-buy-from-brokerages-2026-04-29/
Xencor (NASDAQ:XNCR) Stock Price Down 8% - Should You Sell?
April 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/xencor-nasdaqxncr-stock-price-down-8-should-you-sell-2026-04-28/
Xencor (NASDAQ:XNCR) Stock Passes Above 50 Day Moving Average - Time to Sell?
April 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/xencor-nasdaqxncr-stock-passes-above-50-day-moving-average-time-to-sell-2026-04-28/
Xencor (NASDAQ:XNCR) Stock Rating Upgraded by Wall Street Zen
April 18, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/xencor-nasdaqxncr-stock-rating-upgraded-by-wall-street-zen-2026-04-18/
Xencor (NASDAQ:XNCR) Shares Pass Above Fifty Day Moving Average - Time to Sell?
April 14, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/xencor-nasdaqxncr-shares-pass-above-fifty-day-moving-average-time-to-sell-2026-04-14/
JP Morgan Downgrades Xencor (XNCR)
March 25, 2026  |  msn.comhttps://www.msn.com/en-us/money/topstocks/jp-morgan-downgrades-xencor-xncr/ar-AA1Zlttc
Xencor (XNCR) Receives a Buy from Wedbush
March 17, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/XNCR/pressreleases/607730/xencor-xncr-receives-a-buy-from-wedbush/
Xencor, Inc. (XNCR) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
March 11, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4881189-xencor-inc-xncr-presents-at-barclays-28th-annual-global-healthcare-conference-transcript
Xencor (NASDAQ:XNCR) SVP Sells $19,472.34 in Stock
March 10, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-xncr-insider-buying-and-selling-2026-03-10/
Xencor, Genentech to End Protein Therapeutics Collaboration
March 9, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/xencor-genentech-to-end-protein-therapeutics-collaboration?utm_source=marketbeat.com&utm_medium=referral
Xencor (NASDAQ:XNCR) SVP Sells $17,754.80 in Stock
March 5, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-xncr-insider-buying-and-selling-2026-03-05/
Royalty Rift: Alexion Cuts Off US Royalty Payments To Xencor
March 5, 2026  |  benzinga.comhttps://www.benzinga.com/news/health-care/26/03/51060353/royalty-rift-alexion-cuts-off-us-royalty-payments-to-xencor
Xencor Announces Change to Ultomiris® Royalty Revenue Forecast
March 4, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/xencor-announces-change-ultomiris-royalty-210100262.html
Xencor Reports Fourth Quarter and Full Year 2025 Financial Results
February 25, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260225902842/en/xencor-reports-fourth-quarter-and-full-year-2025-financial-results/
What Catalysts Are Rewriting The Xencor (XNCR) Story In A Recovering Biopharma Sector
February 9, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/catalysts-rewriting-xencor-xncr-story-231143082.html
Xencor (XNCR): BofA Bullish on US Biopharmaceuticals Coverage
January 29, 2026  |  insidermonkey.comhttps://www.insidermonkey.com/blog/xencor-xncr-bofa-bullish-on-us-biopharmaceuticals-coverage-1683738/
Could Early XmAb819 Signals Reshape Xencor’s (XNCR) Broader T‑Cell Engager Investment Narrative?
January 20, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/could-early-xmab819-signals-reshape-120747270.html
Xencor (XNCR) Valuation Check After New Oncology And Autoimmune Pipeline Milestones
January 19, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/xencor-xncr-valuation-check-oncology-021010180.html
Barclays Sticks to Its Buy Rating for Xencor (XNCR)
January 11, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/XNCR-Q/pressreleases/36979718/barclays-sticks-to-its-buy-rating-for-xencor-xncr/
Xencor Outlines Priorities, Shares Sink
January 8, 2026  |  baystreet.cahttps://www.baystreet.ca/stockstowatch/22428/Xencor-Outlines-Priorities-Shares-Sink
Xencor Highlights Corporate Priorities and 2026 Pipeline Milestones
January 8, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260108654667/en/xencor-highlights-corporate-priorities-and-2026-pipeline-milestones/
Bank of America Securities Sticks to Their Hold Rating for Xencor (XNCR)
January 8, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/XNCR-Q/pressreleases/36924673/bank-of-america-securities-sticks-to-their-hold-rating-for-xencor-xncr/
Xencor price target raised to $20 from $17 at BofA
January 6, 2026  |  msn.comhttps://www.msn.com/en-us/money/topstocks/xencor-price-target-raised-to-20-from-17-at-bofa/ar-AA1TGVyM
Xencor: Fortress Balance Sheet Bodes Well For XmAb819 And XmAb942
January 1, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4856682-xencor-fortress-balance-sheet-bodes-well-for-xmab819-and-xmab942
Xencor (NASDAQ:XNCR) VP Sells $1,153,329.24 in Stock
December 28, 2025  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-xncr-insider-buying-and-selling-2025-12-28/
Xencor (NASDAQ:XNCR) CEO Bassil Dahiyat Sells 114,377 Shares
December 27, 2025  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-xncr-insider-buying-and-selling-2025-12-27/
Barclays Reaffirms Their Buy Rating on Xencor (XNCR)
December 19, 2025  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/XNCR/pressreleases/36684357/barclays-reaffirms-their-buy-rating-on-xencor-xncr/
Xencor price target raised to $26 from $23 at Barclays
December 17, 2025  |  msn.comhttps://www.msn.com/en-us/money/topstocks/xencor-price-target-raised-to-26-from-23-at-barclays/ar-AA1SwVmp
Analysts Offer Insights on Healthcare Companies: Teleflex (TFX) and Xencor (XNCR)
December 11, 2025  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/XNCR-Q/pressreleases/36570225/analysts-offer-insights-on-healthcare-companies-teleflex-tfx-and-xencor-xncr/
Xencor issued US patent for Xtend FC domain
December 9, 2025  |  msn.comhttps://www.msn.com/en-us/money/general/xencor-issued-us-patent-for-xtend-fc-domain/ar-AA1S1ff1
Xencor Announces Extension of U.S. Patent Term on Certain Xtend™ Antibodies
December 9, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/xencor-announces-extension-u-patent-120000683.html
Truist Financial Initiates a Buy Rating on Xencor (XNCR)
November 26, 2025  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/XNCR-Q/pressreleases/36157288/truist-financial-initiates-a-buy-rating-on-xencor-xncr/
Truist Securities Initiates Coverage of Xencor (XNCR) with Buy Recommendation
November 25, 2025  |  msn.comhttps://www.msn.com/en-us/money/topstocks/truist-securities-initiates-coverage-of-xencor-xncr-with-buy-recommendation/ar-AA1R5CC5
Xencor initiated with a Buy at Truist
November 24, 2025  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/xencor-initiated-with-a-buy-at-truist/ar-AA1R3jB1
Get Xencor News Delivered to You Automatically

Sign up to receive the latest news and ratings for XNCR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

XNCR Media Mentions By Week

XNCR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

XNCR
News Sentiment
▼
0.53

0.61
▲
Average
Medical
News Sentiment

XNCR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

XNCR Articles
This Week
▼
11

3
▲
XNCR Articles
Average Week

Get the Latest News and Ratings for XNCR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Xencor and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools

Related Companies
Headlines Tools

This page (NASDAQ:XNCR) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Trump is positioned. Elon lights the fuse.
Bitcoin is back above $80,000. Altcoins are pumping. ETF inflows are accelerating. The CLARITY Act… the most b...
Crypto 101 Media | Sponsoredtc pixel
Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...
The Tomorrow Investor | Sponsoredtc pixel
I’m sounding the alarm
Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...
Porter & Company | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel